Valeria Accortanzo

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

Isabella Castellano, Elena Allìa, Valeria Accortanzo et al. · Breast Cancer Research and Treatment · 2010 · 192 citations · Full text

Significant Prognostic Factor, Breast Oncology, Medicine +8

Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

Lucia Del Mastro, Francesca Poggio, Eva Blondeaux et al. · The Lancet Oncology · 2022 · 46 citations

End-of-study Results, Breast Oncology, Early-stage Breast Cancer +6

Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study

Isabella Castellano, Caterina Marchiò, Mariano Tomatis et al. · Modern Pathology · 2009 · 23 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +9

5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial

Lucia Del Mastro, Alessia Levaggi, Andrea Michelotti et al. · Breast Cancer Research and Treatment · 2015 · 15 citations

Cyclophosphamide Versus Epirubicin, Breast Oncology, Medicine +5